Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation

Objectives: To assess the clinical effectiveness and cost-effectiveness of deferasirox for the treatment of iron overload associated with regular blood transfusions in patients with chronic anaemia such as beta-thalassaemia major (beta-TM) and sickle cell disease (SCD). Data sources: Electronic data...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: C McLeod, N Fleeman, J Kirkham, A Bagust, A Boland, P Chu, R Dickson, Y Dundar, J Greenhalgh, B Modell, A Olujohungbe, P Telfer, T Walley
Médium: Artigo
Jazyk:Inglês
Vydáno: NIHR Journals Library 2009-01-01
Edice:Health Technology Assessment
Témata:
deferasirox
iron-overload
sickle-cell-disease
beta-thalassaemia
transfusionalhaemosiderosis
iron-chelating-agent
On-line přístup:https://doi.org/10.3310/hta13010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky